Breathtec BioMedical Inc.

(BTH:CNX)

By |
Breathtec BioMedical Inc.

Profile

Breathtec Biomedical, Inc. (“Breathtec”) was formed to propel innovative research in the area of breath analysis as a medical screening tool. Our efforts are aimed at leading the development of commercially viable methods for the early screening of diseases such as lung & breast cancers, neurodegenerative diseases (eg: Alzheimer’s / Parkinson’s), tuberculosis, diabetes, liver disease and more.

Issuer Information

Exchange: CNQ
CEO: Guy LaTorre
Issuer Type: CS - Common Stock
Sector/Industry: Cyclical
NAICS: In-Vitro Diagnos
$ 0.11 $ -0.015 (-12.50%)
Last Price 0.11 Change $ -0.015 Change % -12.50 Tick N/A
Bid 0.10 Bid Size 51,000.00 Ask 0.11 Ask Size 21,000.00
Open 0.12 High 0.12 Low 0.11 Prev Close 0.12
Last Trade Volume 82,700 52 Wk Hi 0.32 52 Wk Low 0.075
Market Cap 5.7 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 54,752,024.00 EPS (TTM) -0.03 PE Ratio N/A Exchange CSE